Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Related Articles by Review for PubMed (Select 350860)

1.

High-dose pyridoxine in tardive dyskinesia.

DeVeaugh-Geiss J, Manion L.

J Clin Psychiatry. 1978 Jun;39(6):573-5.

PMID:
350860
2.

Dyskinesia: L-dopa-induced and tardive dyskinesia.

Rascol O, Fabre N.

Clin Neuropharmacol. 2001 Nov-Dec;24(6):313-23. Review.

PMID:
11801806
3.

Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives.

Kulkarni SK, Naidu PS.

Drugs Today (Barc). 2003 Jan;39(1):19-49. Review.

PMID:
12669107
4.

[Utility of quetiapine in tardive dyskinesia].

Navarro Pacheco BV, Montejo González AL, Martín Carrasco M.

Actas Esp Psiquiatr. 2003 Nov-Dec;31(6):347-52. Review. Spanish.

PMID:
14639511
5.

Lithium carbonate in the treatment of movement disorders. A critical review.

Yassa R, Ananth J.

Int Pharmacopsychiatry. 1980;15(5):301-8. Review.

PMID:
6114936
6.

Distinguishing akathisia and tardive dyskinesia: a review of the literature.

Munetz MR, Cornes CL.

J Clin Psychopharmacol. 1983 Dec;3(6):343-50. Review.

PMID:
6139392
7.

Management of tardive dyskinesia: current update.

Simpson GM, Pi EH, Sramek JJ Jr.

Drugs. 1982 May;23(5):381-93. Review.

PMID:
7047137
8.

Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials.

Tammenmaa IA, Sailas E, McGrath JJ, Soares-Weiser K, Wahlbeck K.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Nov;28(7):1099-107. Review.

PMID:
15610922
9.

Oxidative mechanisms and tardive dyskinesia.

Lohr JB, Kuczenski R, Niculescu AB.

CNS Drugs. 2003;17(1):47-62. Review.

PMID:
12467492
10.

[Tardive dyskinesia (author's transl)].

Reches A, Melamed E.

Harefuah. 1977 May 15;92(10):458-61. Review. Hebrew. No abstract available.

PMID:
328348
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk